Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer

MLA

Lieven Meerpoel, et al. “Abstract 4747: Design and Synthesis of a Series Highly Potent and Bioavailable FASN KR Domain Inhibitors for Cancer.” Cancer Research, vol. 74, Oct. 2014, p. 4747. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bbc77f2de582fc793cad2cd350548d6d&authtype=sso&custid=ns315887.

APA

Lieven Meerpoel, Gilles Bignan, Luc Van Nuffel, Peter Vermeulen, Ron Gilissen, Tianbao Lu, Max Cummings, Christophe Meyer, Bruce L. Grasberger, Peter J. Connolly, Michael H. Parker, Erwin Fraiponts, Richard Alexander, Karine Smans, Boudewijn Janssens, Danielle Peeters, Norbert Esser, Donald William Ludovici, Carsten Schubert, … Sabine De Breucker. (2014). Abstract 4747: Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer. Cancer Research, 74, 4747.

Chicago

Lieven Meerpoel, Gilles Bignan, Luc Van Nuffel, Peter Vermeulen, Ron Gilissen, Tianbao Lu, Max Cummings, et al. 2014. “Abstract 4747: Design and Synthesis of a Series Highly Potent and Bioavailable FASN KR Domain Inhibitors for Cancer.” Cancer Research 74 (October): 4747. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........bbc77f2de582fc793cad2cd350548d6d&authtype=sso&custid=ns315887.